India's largest drugmaker Sun Pharmaceutical on Tuesday posted a 59% year-on-year decline in its profit to ₹912 crore for the September quarter. The company's revenue declined 19.4% to ₹6,650.34 crore during the quarter. The company's MD Dilip Sanghvi said a challenging US generic pricing environment along with continued investments in building the global specialty business impacted the quarter.